Diab H, Fuquay T, Datta P, Bickel U, Thompson J, Krutsch K
Key findings: Prescribing trends Using a subset of Truveta Data, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2019 and December 31, 2025
Peiser, C
After choosing tirzepatide or semaglutide, Winter Park, FL, patients often experience increased empowerment and clarity around food choices, allowing even modest goals to feel achievable and sustainable
The levels of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1) and NRF2 are reduced in human tissues in obesity and diabetes [102]
These therapies, primarily administered as subcutaneous injectables for ease of at-home use, act by mimicking the native GLP1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon release, lowering HbA1c levels, and promoting weight loss - all while carrying a minimal risk of hypoglycemia when used alone